🇺🇸 FDA

Drug profile · INN

carisoprodol

CARISOPRODOL

approved
US status
approved
Patents linked
8
News articles
0

Quick answer

carisoprodol (CARISOPRODOL) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN carisoprodol
Brand CARISOPRODOL
Route ORAL
Formulation CAPSULE
Originator Teva Pharma GmbH

Related patents

Search patents →

  1. US 12427155

    Treatment for tau-related diseases

    Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12419873

    Use of JAK inhibitors in preparation of drugs for treating JAK kinase-related diseases

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12414999

    Compositions and methods relating to macrophages and/or monocytes with adhered particles

    Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12396974

    Ketone ester as a therapeutic treatment of Covid-19 and related viral infections

    Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12364708

    Injectable scaffold for treatment of intracranial aneurysms and related technology

    Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12359223

    Systems and methods for modulating chromosomal rearrangements

    Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12350258

    Compositions and methods for treatment of skin-related diseases and promoting dermatological health

    Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12350298

    Microbiome related immunotherapies

    Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is carisoprodol?

carisoprodol (CARISOPRODOL) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for carisoprodol?

CARISOPRODOL is a marketed brand name for carisoprodol. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of carisoprodol?

carisoprodol has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.